前列腺腺癌经细胞毒性基因治疗、放疗和雄激素剥夺治疗后孤立性软脑膜复发
本文报道一例63岁高危前列腺癌患者,在接受雄激素剥夺、放疗和细胞毒性基因治疗的I-II期试验后47个月出现孤立性软脑膜复发,接受腰椎骶椎放疗和3个颅内病灶立体定向放射外科治疗,复发后14个月死亡,尸检显示弥漫性脊髓软脑膜病变和软脑膜基底部颅内病灶,无其他转移。
要点
- 前列腺腺癌软脑膜病变非常罕见,孤立性软脑膜复发此前仅报道过一次。
- 本例复发后接受腰椎骶椎放疗和3个颅内病灶立体定向放射外科治疗。
- 复发原因不明,推测可能与初始细胞毒性基因治疗联合放疗和雄激素剥夺有关。
核心结论
- 该患者孤立性软脑膜复发的原因未知,推测可能与初始细胞毒性基因治疗联合放疗和雄激素剥夺有关。
研究设计与样本
- 病例报告:一名63岁高危前列腺癌患者参与I-II期试验,接受雄激素剥夺、放疗和细胞毒性基因治疗。
主要发现
- 患者初始获得生化控制,诊断后47个月出现孤立性软脑膜复发。
- 复发后接受雄激素剥夺、腰椎骶椎放疗和3个颅内病灶立体定向放射外科治疗,复发后14个月死亡。
- 尸检显示弥漫性脊髓软脑膜病变、软脑膜基底部颅内病灶,无其他转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Leptomeningeal disease in prostate adenocarcinoma is very rare. Solitary leptomeningeal recurrence from prostate adenocarcinoma has only been previously reported once in the published literature. METHODS AND MATERIALS: A 63-year-old man with high-risk prostate cancer was treated in a phase I-II trial with androgen deprivation, radiation therapy, and cytotoxic gene therapy. He initially had biochemical control but experienced solitary leptomeningeal recurrence 47 months after diagnosis. RESULTS: He received androgen deprivation, radiation therapy to the lumbar and sacral spine, and stereotactic radiosurgery to 3 intracranial foci of disease. He died 14 months after leptomeningeal recurrence. Autopsy showed diffuse spinal leptomeningeal disease, leptomeningeal based intracranial lesions, and no other metastasis. CONCLUSIONS: The cause for solitary leptomeningeal recurrence in this patient is unknown. Although there may be many possible mechanisms, we speculate that it could be related to his initial treatment with cytotoxic gene therapy along with radiation therapy and androgen deprivation.
引用
- Chevli N, Curtis AE, Powell S, et al. Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy. Adv Radiat Oncol. 2021. PMID: 34195498. doi:10.1016/j.adro.2021.100711
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。